Adjunctive interventions in myocardial infarction: the role of statin therapy.

Current Atherosclerosis Reports
Peter H Jones, J A Farmer

Abstract

Statin therapy has reduced cardiovascular morbidity and mortality across the spectrum of atherosclerosis. The administration of statins has been demonstrated to be effective in primary and secondary prevention clinical trials evaluating patients with high and low risk-factor profiles. The presumed mechanism of benefit of hypolipidemic therapy in the prevention of atherosclerotic disease was a reduction in the deposition of atherogenic lipoproteins in vulnerable areas of the coronary vasculature. Subsequent experimental studies with statins demonstrated a variety of potentially beneficial effects that would extend clinical benefit beyond lipid-lowering per se. Statin therapy beneficially alters inflammation, coagulation and fibrinolytic parameters, endothelial function, vasoreactivity, and platelet function. The demonstration of the non-lipid or pleiotropic effects provided the theoretical basis for a possible role as an adjunctive therapy in acute coronary syndromes. Retrospective analysis of a variety of early trials indicated a potential benefit of statins during acute ischemic syndromes. Recent clinical trials have addressed this important clinical question in a prospective controlled manner. The Myocardial Ischemia Reductio...Continue Reading

References

Sep 12, 2000·Current Cardiology Reports·M A Albert, P M Ridker
Apr 13, 2001·JAMA : the Journal of the American Medical Association·G G SchwartzUNKNOWN Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study Investigators
Dec 12, 2001·Circulation Research·U Schönbeck, P Libby
Mar 27, 2002·Circulation·Christopher HeeschenUNKNOWN Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Investigators
Dec 11, 2002·European Heart Journal·A H LiemUNKNOWN FLuvastatin On Risk Diminishment after Acute myocardial infarction study group
Feb 14, 2003·The New England Journal of Medicine·Jonathan M HillToren Finkel
Mar 10, 2004·The New England Journal of Medicine·Christopher P CannonUNKNOWN Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 Investigators
Jun 4, 2004·Thrombosis and Haemostasis·Anetta UndasJacek Musial
Sep 1, 2004·JAMA : the Journal of the American Medical Association·James A de LemosUNKNOWN Investigators
Oct 27, 2004·Archives of Internal Medicine·Frederick A SpencerUNKNOWN National Registry of Myocardial Infarction
Nov 9, 2004·Atherosclerosis. Supplements·T R PedersenUNKNOWN Scandinavian Simvastatin Survival Study Group
Nov 24, 2004·Clinical Chemistry and Laboratory Medicine : CCLM·Martina BrueckmannKarl K Haase
Apr 12, 2005·Annual Review of Pharmacology and Toxicology·James K Liao, Ulrich Laufs
Apr 30, 2005·Arteriosclerosis, Thrombosis, and Vascular Biology·Sridevi DevarajIshwarlal Jialal
Feb 16, 2006·Seminars in Thrombosis and Hemostasis·Rachel Tilley, Nigel Mackman
Aug 24, 2006·Expert Opinion on Pharmacotherapy·Michael H Davidson, Jennifer G Robinson
Dec 16, 2006·Current Atherosclerosis Reports·Sridevi DevarajIshwarlal Jialal
Dec 16, 2006·The American Journal of Cardiology·Peter Libby
Jan 2, 2007·Trends in Immunology·John Greenwood, Justin C Mason
Mar 31, 2007·Circulation Research·Marie-Ange Renault, Douglas W Losordo
Jul 21, 2007·The Medical Clinics of North America·Mario GösslAmir Lerman

❮ Previous
Next ❯

Citations

Apr 2, 2009·Nature Reviews. Drug Discovery·John D Baxter, Paul Webb
May 27, 2016·Angewandte Chemie·Santanu MondalGovindasamy Mugesh

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carotid Artery Diseases

Carotid artery disease is a group of pathological conditions of the carotid artery. Discover the latest research on carotid artery disease here.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.